Integration of technologies for hepatic tissue engineering
- PMID: 17195468
- DOI: 10.1007/10_029
Integration of technologies for hepatic tissue engineering
Abstract
The liver is the largest internal organ in the body, responsible for over 500 metabolic, regulatory, and immune functions. Loss of liver function leads to liver failure which causes over 25,000 deaths/year in the United States. Efforts in the field of hepatic tissue engineering include the design of bioartificial liver systems to prolong patient's lives during liver failure, for drug toxicity screening and for the study of liver regeneration, ischemia/reperfusion injury, fibrosis, viral infection, and inflammation. This chapter will overview the current state-of-the-art in hepatology including isolated perfused liver, culture of liver slices and tissue explants, hepatocyte culture on collagen "sandwich" and spheroids, coculture of hepatocytes with non-parenchymal cells, and the integration of these culture techniques with microfluidics and reactor design. This work will discuss the role of oxygen and medium composition in hepatocyte culture and present promising new technologies for hepatocyte proliferation and function. We will also discuss liver development, architecture, and function as they relate to these culture techniques. Finally, we will review current opportunities and major challenges in integrating cell culture, bioreactor design, and microtechnology to develop new systems for novel applications.
Similar articles
-
Microfabricated grooved substrates as platforms for bioartificial liver reactors.Biotechnol Bioeng. 2005 Jun 5;90(5):632-44. doi: 10.1002/bit.20463. Biotechnol Bioeng. 2005. PMID: 15834948
-
An artificial liver sinusoid with a microfluidic endothelial-like barrier for primary hepatocyte culture.Biotechnol Bioeng. 2007 Aug 1;97(5):1340-6. doi: 10.1002/bit.21360. Biotechnol Bioeng. 2007. PMID: 17286266
-
Microfluidic PDMS (polydimethylsiloxane) bioreactor for large-scale culture of hepatocytes.Biotechnol Prog. 2004 May-Jun;20(3):750-5. doi: 10.1021/bp0300568. Biotechnol Prog. 2004. PMID: 15176878
-
Applications of MEMS technologies in tissue engineering.Tissue Eng. 2007 Dec;13(12):2839-54. doi: 10.1089/ten.2007.0214. Tissue Eng. 2007. PMID: 17997691 Review.
-
Bioartificial liver systems: current status and future perspective.J Biosci Bioeng. 2005 Apr;99(4):311-9. doi: 10.1263/jbb.99.311. J Biosci Bioeng. 2005. PMID: 16233796 Review.
Cited by
-
Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies.Stem Cell Res. 2012 Nov;9(3):196-207. doi: 10.1016/j.scr.2012.06.004. Epub 2012 Jun 28. Stem Cell Res. 2012. PMID: 22885101 Free PMC article.
-
Characterization of a long-term mouse primary liver 3D tissue model recapitulating innate-immune responses and drug-induced liver toxicity.PLoS One. 2020 Jul 9;15(7):e0235745. doi: 10.1371/journal.pone.0235745. eCollection 2020. PLoS One. 2020. PMID: 32645073 Free PMC article.
-
Embryonic and induced pluripotent stem cells as a model for liver disease.Crit Rev Biomed Eng. 2009;37(4-5):377-98. doi: 10.1615/critrevbiomedeng.v37.i4-5.40. Crit Rev Biomed Eng. 2009. PMID: 20528732 Free PMC article. Review.
-
Long-term coculture strategies for primary hepatocytes and liver sinusoidal endothelial cells.Tissue Eng Part C Methods. 2015 Apr;21(4):413-22. doi: 10.1089/ten.TEC.2014.0152. Epub 2014 Nov 6. Tissue Eng Part C Methods. 2015. PMID: 25233394 Free PMC article.
-
Biomaterials for liver tissue engineering.Hepatol Int. 2014 Apr;8(2):185-97. doi: 10.1007/s12072-013-9503-7. Epub 2013 Dec 27. Hepatol Int. 2014. PMID: 26202501
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources